The High Cost of Caution, Part 2
Sometimes there’s not enough regulation, and sometimes there’s too much regulation.
But it’s not the hostile regulation that you need to worry about – the kind that pops up after a major financial crisis, like the one we had in the U.S. just a few years ago.
Rather, in markets where the barriers to entry are already so high – like the highly regulated pharmaceutical industry -it’s the creeping regulations you have to watch out for – and they can be deadly. Juan Enriquez explains in the video below…
